Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001632304-18-000002
Filing Date
2018-09-21
Accepted
2018-09-21 13:53:12
Documents
1
Effectiveness Date
2018-09-21
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 10290
  Complete submission text file 0001632304-18-000002.txt   11318
Mailing Address 955 MASSACHUSETTS AVE CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVE CAMBRIDGE MA 02139 339-203-1076
X4 Pharmaceuticals, Inc. (Filer) CIK: 0001632304 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-298854 | Film No.: 181081224